Proceedings/Current concepts in ophthalmology: implications for new drug development, symposium, Americana Great Gorge Resort NJ, October 24, 1985HUGER, F. P; PACK, F. D.Drug development research. 1985, Vol 6, Num 3, pp 177-261, issn 0272-4391Conference Proceedings

Synthesis of 3-aryl-6H-isoxazolo[3,4-d]pyrazolo[3,4-b]pyridines and 3-aryl-6H-isoxazolo[5,4-d]pyrazolo[3,4-b]pyridinesSHUTSKE, G. M; HUGER, F. P.Journal of heterocyclic chemistry. 1988, Vol 25, Num 3, pp 703-709, issn 0022-152XArticle

Vascular and cardiac effects of HP 406 and nifedipine in vitro and in conscious spontaneously hypertensive rats and renal hypertensive dogsHUBBARD, J. W; KAPPLES, J. F; NORDSTROM, S. T et al.Drug development research. 1988, Vol 5, Num 1, pp 17-29, issn 0272-4391Article

Synthesis and biological activity of putative mono-hydroxylated metabolites of velnacrineSHUTSKE, G. M; BORES, G. M; BRADSHAW, K. C et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 865-870Book Chapter

Adenylate cyclase stimulation and intraocular pressure reduction by forskolin analogsCAPRIOLI, J; SEARS, M; MEAD, A et al.Journal of ocular pharmacology. 1989, Vol 5, Num 3, pp 181-187, issn 8756-3320Article

Synthesis and in vitro acetylcholinesterase inhibitory activity of some 1-substituted analogues of velnacrineKAPPLES, K. J; SHUTSKE, G. M; BORES, G. M et al.Bioorganic & medicinal chemistry letters (Print). 1993, Vol 3, Num 12, pp 2789-2792, issn 0960-894XArticle

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeuticsSHUTSKE, G. M; PIERRAT, F. A; KAPPLES, K. J et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 8, pp 1805-1813, issn 0022-2623, 9 p.Article

(±)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicitySHUTSKE, G. M; PIERRAT, F. A; CORNFELDT, M. L et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 7, pp 1278-1279, issn 0022-2623Article

Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent. II: In vitro profileHUGER, F. P; SMITH, C. P; YULIN CHIANG et al.Drug development research. 1987, Vol 11, Num 3-4, pp 169-175, issn 0272-4391Article

Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's diseaseKLEIN, J. T; DAVIS, L; LANDAU, E et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 2, pp 570-581, issn 0022-2623Article

N-(n-propyl)-N-(1-fluoro-4-pyridinyl)-1H-3-methylindol-1-amine hydrochloride (HP 184) : in vitro spontaneous release of acetylcholine and norepinephrineSMITH, C. P; BROUGHAM, L. R; HUGER, F. P et al.Drug development research. 1993, Vol 30, Num 4, pp 203-212, issn 0272-4391Article

Aminopyridine carbamic acid esters : synthesis and potential as acetylcholinesterase inhibitors and acetylcholine releasersSHUTSKE, G. M; TOMER, J. D; KAPPLES, K. J et al.Journal of pharmaceutical sciences. 1992, Vol 81, Num 4, pp 380-385, issn 0022-3549Article

Synthesis and biological evaluation of a series of substituted N-alkoxymides and -amides as potential atypical antipsychotic agentsHRIB, N. J; JURCAK, J. G; HUGER, F. P et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 3, pp 1068-1072, issn 0022-2623, 5 p.Article

Synthesis of 5-phenylpyrrolo[1,2-b][1,2,5]-triazepin-2(3H)-onesHAMER, R. R. L; EFFLAND, R. C; KLEIN, J. T et al.Journal of heterocyclic chemistry. 1988, Vol 25, Num 2, pp 517-521, issn 0022-152XArticle